OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Gastroenterology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study	83
Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study	69
The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990–2019	69
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study	58
Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant	56
Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis	55
The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis	55
Sedation practices for routine gastrointestinal endoscopy: a systematic review of recommendations	55
Dietary patterns and risk of non-alcoholic fatty liver disease	49
Adverse events of video capsule endoscopy over the past two decades: a systematic review and proportion meta-analysis	49
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran	46
Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome	46
The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database	45
Nomogram for predicting overall survival in colorectal cancer with distant metastasis	45
A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease	43
Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis	41
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study	41
Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections	40
Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review	40
Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial	36
Beyond the scope and the glue: update on evaluation and management of gastric varices	35
Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)	34
The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study	33
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome	33
Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis	30

Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study	30
Deep learning for sensitive detection of Helicobacter Pylori in gastric biopsies	28
The global, regional, and national burden of appendicitis in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019	28